Developing MRI Technologies for Atrial Fibrillation

Part of paid clinical trials in Cleveland, Ohio.

Sponsor
The Cleveland Clinic
Study ID
NCT07083115
Status
Enrolling By Invitation

Conditions

  • Atrial Fibrillation (AF)

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

To measure image quality of damaged areas of the heart in patients with Atrial fibrillation using the contrast Gadopiclenol vs conventional Gadolinium-based contrast agents(GBCA)

Key Dates

Start date
Jan 16, 2025
Status verified
Mar 2026
Primary completion
Sep 30, 2027
Completion
Sep 30, 2028

Study Design

Enrollment
50 participants (estimated)

Primary Outcome Measure

Image quality [ Time Frame: At completion of each MRI ]

Locations (1)

FacilityCityStateZIPSite coordinators
Cleveland ClinicClevelandOhio44106-

Find similar trials in Cleveland, OH

By research site
Cleveland Clinic· Cleveland, OH

Related Studies